Encysive sees Thelin sales of $10.5-$11.5 mln in 2007
Dec 14 (Reuters) - Encysive Pharmaceuticals Inc ENCY.O said it expects 2007 sales of its hypertension drug, Thelin, to be about $10.5 million to $11.5 million.
For 2008, it expects the drug's sales to be about $40 million to $50 million.
The drug is approved in the European Union, Canada and Australia, the company said in a statement. (Reporting by Avishek Mishra in Bangalore; Editing by Vinu Pilakkott)
© Thomson Reuters 2017 All rights reserved.